Provided by Tiger Trade Technology Pte. Ltd.

Atrium Therapeutics

13.20
-0.2800-2.08%
Post-market: 13.200.00000.00%19:30 EDT
Volume:180.68K
Turnover:2.39M
Market Cap:225.79M
PE:-3.42
High:13.59
Open:13.53
Low:12.96
Close:13.48
52wk High:16.77
52wk Low:11.13
Shares:17.11M
Float Shares:15.72M
Volume Ratio:0.84
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.8578
EPS(LYR):-3.1905
ROE:-43.98%
ROA:-399.25%
PB:1.05
PE(LYR):-4.14

Loading ...

Atrium Therapeutics Q1 EPS $(0.97) Beats $(1.10) Estimate, Sales $19.635M Beat $2.000M Estimate

Benzinga Earnings
·
May 15

Datar Cancer Genetics Receives Landmark US FDA Clearance for CellDx-Tissue, a Comprehensive Genomic Profiling Assay for Solid Tumors Using DNA + RNA

prnewswire
·
May 14

EVEREST MED Shares Climb Over 3% Following Release of Initial Human Data for mRNA Cancer Vaccine EVM16

Stock News
·
May 14

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

GlobeNewswire
·
May 14

Thalia Therapeutics CEO Outlines Strategic Pivot to High-Value RNA Therapies

TIPRANKS
·
May 13

Capital Universities Strengthen Role as Pillars in Fundamental Research

Deep News
·
May 13

Akari Therapeutics Secures Key European Patent For Its Novel RNA Splicing Modulator ADC Payload, Strengthening Global IP Estate For All Major Global Markets

GlobeNewswire
·
May 12

ProQR Posts Q1 2026 Results as Axiomer RNA Editing Pipeline Advances

TIPRANKS
·
May 12

ProQR Announces First Quarter 2026 Operating and Financial Results

GlobeNewswire
·
May 12

ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform

GlobeNewswire
·
May 11

Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update

GlobeNewswire
·
May 07

WA biotech duo takes aim at diabetes beyond Ozempic

The West Australian
·
May 07

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

GlobeNewswire
·
May 04

ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors

GlobeNewswire
·
Apr 30

ArcticZymes Wins Key Patent to Drive Expansion in RNA Therapeutics Manufacturing

TIPRANKS
·
Apr 30

Circio Teams With TraffikGene on Non-Viral Delivery for Circular RNA Therapies

TIPRANKS
·
Apr 29

CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation

GlobeNewswire
·
Apr 28

Wave Life Sciences Reports Q1 Results, Advances RNA Pipeline

TIPRANKS
·
Apr 28

Wave Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
Apr 28

Circio’s circVec Gene Therapy Platform Wins Spotlight at Global ASGCT Meeting

TIPRANKS
·
Apr 28